Biosyntech (Biosyntech) EPS (Basic) : $-0.11 (TTM As of Dec. 2009)

View and export this data going back to 2000. Start your Free Trial

What is Biosyntech EPS (Basic)?

Biosyntech's basic earnings per share (Basic EPS) for the three months ended in Dec. 2009 was $-0.03. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2009 was $-0.11.

Biosyntech's EPS (Diluted) for the three months ended in Dec. 2009 was $-0.03. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2009 was $-0.11.

Biosyntech's EPS without NRI for the three months ended in Dec. 2009 was $-0.03. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2009 was -0.10.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Biosyntech EPS (Basic) Historical Data

The historical data trend for Biosyntech's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosyntech EPS (Basic) Chart

Biosyntech Annual Data

Trend

Mar00

Mar01

Mar02

Mar03

Mar04

Mar05

Mar06

Mar07

Mar08

Mar09

EPS (Basic)

Get a 7-Day Free Trial

-0.12

-0.15

-0.08

-0.10

Biosyntech Quarterly Data
	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09
EPS (Basic)	Get a 7-Day Free Trial															-0.04	-0.02	-0.03	-0.03	-0.03

Biosyntech EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Biosyntech's Basic EPS for the fiscal year that ended in Mar. 2009 is calculated as

Basic EPS (A: Mar. 2009 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-10.233	-	0)	/	95.902
	=	-0.11

Biosyntech's Basic EPS for the quarter that ended in Dec. 2009 is calculated as

Basic EPS (Q: Dec. 2009 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-3.208	-	0)	/	106.082
	=	-0.03

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2009 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.11

Biosyntech (OTCPK:BSYI) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Biosyntech EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Biosyntech's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosyntech (Biosyntech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosyntech Inc (OTCPK:BSYI) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

475 Boulevard Armand-Frappier, Laval, QC, CAN, H7V 4B3

Website

http://www.biosyntech.com

Biosyntech Inc is engaged in developing advanced biotherapeutics thermogels specifically designed for tissue repair and delivery of therapeutic agents. The company's products include BST-CarGel, BST-InPod, BST-DermOn, BST-Ossifil and BST-Ossifix and BST-Disc for intervertebral disc restoration.

Biosyntech (Biosyntech) Headlines

No Headlines